Obesity Ups Risks in Pediatric Procedural Sedation

This article originally appeared here.
Share this content:
Obesity Ups Risks in Pediatric Procedural Sedation
Obesity Ups Risks in Pediatric Procedural Sedation

FRIDAY, June 12, 2015 (HealthDay News) -- For pediatric patients undergoing procedural sedation, obesity is associated with increased risk of adverse respiratory events and frequency of airway interventions, according to research published in the July issue of Pediatric Anesthesia.

Patricia D. Scherrer, M.D., from the Children's Hospitals and Clinics of Minnesota in Minneapolis, and colleagues queried the Pediatric Sedation Research Consortium database of prospectively collected procedural sedation encounters to examine the impact of obesity on pediatric procedural sedation. They compared sedation-related outcomes, adverse events, and therapeutic interventions for obese and nonobese patients. Data were included for 28,792 patients, of whom 17.9 percent were obese.

The researchers found that the likelihood of total adverse events was increased in obese patients (odds ratio, 1.49). There were increases in respiratory events, including airway obstruction, oxygen desaturation, secretions, and laryngospasm (odds ratios, 1.94, 1.99, 1.48, and 2.30, respectively); inability to complete the associated procedure (odds ratio, 1.96); and prolonged recovery (odds ratio, 2.66). Airway intervention, including repositioning, suctioning, jaw thrust, airway adjuncts, and bag-valve-mask ventilation, was more frequently required by obese patients. After multivariate regression analysis, obesity was found to be independently associated with minor and moderate, but not major, adverse events.

"Obesity is an independent risk factor for adverse respiratory events during procedural sedation and is associated with an increased frequency of airway interventions, suggesting that additional vigilance and expertise are required when sedating these patients," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »